Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis (SNS01)

Bitop

Status: Completed

Conditions: Sinusitis

Treatments: Drug: Sinupret forte; Other: Medical Device, Drug-like

Study type: Observational

Funder types: Industry

Identifiers

NCT01684540

NIS SNS01

PPL-047

Details and patient eligibility

About

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Rhinitis Nasal Spray. In addition the effectiveness and safety shall be compared to a Sinupret forte. The patient applies Ectoin® Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.

Enrollment: 66 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female or male individuals ≥ 18 years
• Patients with acute Rhinosinusitis which are treated with Ectoin® Rhinitis Nasal Spray or Sinupret forte during the observational period

Exclusion criteria

• Contra indications according to the label